SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignancies
2011 · Leukemia · 195 citations
https://doi.org/10.1038/leu.2011.148
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
60
Papers
1.3K
Citations
17
h-index
18
i10-index
Veronica Novotny‐Diermayr is an academic researcher from Agency for Science, Technology and Research. The author has contributed to research in topics: Histone Deacetylase Inhibitors Research & Peptidase Inhibition and Analysis & Epigenetics and DNA Methylation. The author has an h-index of 17, co-authored 51 publications.
https://doi.org/10.1038/leu.2011.148
https://doi.org/10.1038/bcj.2011.43
Click to start Chat